Cleared Traditional

K060047 - CARTO RMT EP NAVIGATION SYSTEM V8

K060047 is an FDA 510(k) clearance for CARTO RMT EP NAVIGATION SYSTEM V8, manufactured by Biosense Webster, Inc.. The device is a Class 2 Cardiovascular device with product code DRF cleared through the Traditional 510(k) pathway after a 164-day FDA review.

K060047 · Biosense Webster, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2006
Decision
164d
Days
Class 2
Risk

K060047 is an FDA 510(k) clearance for the CARTO RMT EP NAVIGATION SYSTEM V8. Classified as Catheter, Electrode Recording, Or Probe, Electrode Recording (product code DRF), Class II - Special Controls.

Submitted by Biosense Webster, Inc. (Diamond Bar, US). The FDA issued a Cleared decision on June 19, 2006 after a review of 164 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1220 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Biosense Webster, Inc. devices

FDA 510(k) Submission Details - K060047

510(k) Number K060047 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 06, 2006
Decision Date June 19, 2006
Days to Decision 164 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d slower than avg
Panel avg: 125d · This submission: 164d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRF Device Classification - Class 2, Special Controls

Product Code DRF Catheter, Electrode Recording, Or Probe, Electrode Recording
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRF Catheter, Electrode Recording, Or Probe, Electrode Recording

All 140
Devices cleared under the same product code (DRF) and FDA review panel - the closest regulatory comparables to K060047.
REFLEXION SPIRAL VARIABLE RADIUS CATHETER, MODEL 402804
K062251 · St Jude Medical · Oct 2006
ESOPHAGEAL MAPPING CATHETER, MODEL D-1272-01-S
K061463 · Biosense Webster, Inc. · Aug 2006
REFSTAR EXTERNAL REFERENCE PATCH
K061468 · Biosense Webster, Inc. · Aug 2006
REFSTAR RMT EXTERNAL REFERENCE PATCH
K042998 · Biosense Webster, Inc. · Sep 2005
NAVISTAR RMT STEERABLE TIP DIAGNOSTIC CATHETER
K052083 · Biosense Webster, Inc. · Sep 2005
CORONARY SINUS DEFLECTABLE MAPPING CATHETER, 4 FR, 5 FR, 6 FR & 7 FR
K050877 · Biosense Webster, Inc. · Jun 2005